Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
  • United States
  • France
  • Germany
  • United Kingdom
  • Switzerland
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • China
  • Japan
  • Canada (life sciences hubs)
Investment stages
  • Series A
  • Series B
  • Growth
Industries
  • Biotechnology
  • Digital Health
  • Health Tech
  • Medical Devices
About
The firm supports biotech, digital health, and medtech ventures, leveraging Sanofi’s expertise and ecosystem to scale scientific innovations.
Min check size
$5M
Max check size
$30M
Fund size
NPS

Investment Thesis

Sanofi Ventures is the corporate venture arm of Sanofi, investing in Series A to growth-stage life sciences companies globally.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

The team is composed of experienced life sciences investors and former pharmaceutical executives. They have managed dozens of biotech and medtech deals globally, leveraging Sanofi’s strategic reach to accelerate portfolio growth.

Team

Deborah Palestrant – Partner

Paul Hudson – Strategic Lead

Christian Hogg – Partner

Jason Hafler – Partner

Portfolio

Lexeo Therapeutics

Kymera Therapeutics

Recludix Pharma

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp